Angelini Pharma acquires ThermaCare from GlaxoSmithKline


Angelini Pharma acquired the ThermaCare global business rights, excluding North America, from GSK. The deal also includes the dedicated US manufacturing site for ThermaCare in Albany, Georgia.

The acquired asset supports Angelini Pharma reinforcing both its Consumer Healthcare business and consolidating its International presence. Heat therapy is widely known to help ease muscle pain, reduce soreness, and loosen tight muscles.

ThermaCare uses patented technology that produces real heat to help the body rebuild damaged tissue and accelerate healing. This products are formulated for: Lower Back & Hip, Neck, Wrist & Shoulder, Knee & Elbow, Multi-Purpose Muscle, Multi-Purpose Joint and Menstrual.

Along to prescription drugs, Angelini Pharma is recognized for having built a successful Consumer Healthcare business by consistently delivering high-quality solutions to our customers,” said Angelini Pharma CEO Pierluigi Antonelli.I am convinced that the ThermaCare® deal will represent a significant incremental growth engine for our accelerated international expansion.

- Advertisment -


World’s 500 largest family businesses grew their revenue by 10%

The 500 largest family businesses generate US$8.02t and employ 24.5m people across 47 jurisdictions, according to 2023 EY and...

Must read